Today's Hours: 10:00am - 6:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Michelle Croston, Ian Hodgson, editors.
    Summary: This very first book helps nurses and healthcare practitioners working in the field of HIV care across European to have practical examples of how they could improve/ adapt their services to improve outcomes for people living with HIV. It provides the reader with both knowledge on a variety of different HIV related topic areas and also helps them to translate this learning into a clinical setting. The main focus of the book is to share best practice in HIV nursing, with the aim of providing a practical guide from multiple countries to improve outcomes for people living with HIV. The book also acts as a resource to healthcare practitioners who are interested in working in many places in the world or carrying out research in HIV care.

    Contents:
    The changing landscape of HIV care: Humanistic approaches to care delivery
    How do HIV nurses contribute to HIV care delivery?
    Leadership in HIV nursing: pathing the future
    HIV care in rural areas
    Innovations in care delivery: the need to think creatively
    Reaching vulnerable population to provide care
    Working with young people living with HIV who have cognitive impairment
    Women and HIV
    Maximising LGBTQ access to services
    Care considerations for ageing with HIV
    HIV and Ageing: managing with frailty
    From prevention to successful treatment outcomes: Why we need more engagement of nurse in eastern Europe
    Activism and Community
    Reducing the power of shame: a compassion focused approach for people living with HIV
    Who cares for the workforce? : developing mindfulness and resilience.
    Digital Access Springer 2021
  • Article
    DeVita VT, Lewis BJ, Rozencweig M, Muggia FM.
    Cancer. 1978 Aug;42(2 Suppl):979-90.
    From the standpoint of chemotherapy, the first progress in the treatment of Hodgkin's disease was the identification of the activity of nitrogen mustard in the 1940's. The initial antitumor effect of the drug created a great excitement. However, when all patients later relapsed, there was subsequent dejection and skepticism about the utility of drug therapy. Fortunately, in the 1950's and 1960's, the development of other effective agents (vinca alkaloids, corticosteroids, and methylhydrazines) in conjunction with the elucidation of the principles of combination chemotherapy led to a marked increase in the antitumor response rate of patients with Hodgkin's disease. The value of many of these drug combinations remains under study. Nonetheless, approximately 75% of all patients with advanced Hodgkin's disease treated today with combination chemotherapy can achieve a complete remission. In addition, over half of these remain disease-free long enough to be considered cured. The development of effective treatment, both local (radiotherapy) and systemic (MOPP chemotherapy), has given the clinical investigator the tools to complete, in the 1970's, the therapeutic experiments necessary to refine both the interrelationship between the treatments and their impact upon the natural history of Hodgkin's disease.
    Digital Access Access Options